The CDC’s 2023 Autism and Developmental Disabilities Monitoring report identified autism spectrum disorder in approximately 1 in 36 American 8-year-olds — a substantial increase from 1 in 150 two decades earlier. Better screening, broader diagnostic criteria, and increased awareness account for much of the change, though true prevalence increases are also part of the picture. ASD is a neurodevelopmental condition characterized by differences in social communication and restricted, repetitive patterns of behavior or interests. Diagnosis is now possible reliably as young as 18-24 months, and earlier intervention is associated with better long-term functional outcomes. Understanding the early signs, diagnostic process, and support landscape helps families navigate one of the most consequential diagnoses in pediatrics.
What Autism Spectrum Disorder Is
ASD is defined in the DSM-5-TR by two core diagnostic domains: persistent deficits in social communication and social interaction across multiple contexts (joint attention, social reciprocity, nonverbal communication, relationships), and restricted, repetitive patterns of behavior, interests, or activities (stereotyped movements, insistence on sameness, highly restricted interests, sensory differences). Symptoms must be present in early developmental period, cause clinically significant impairment, and not be better explained by intellectual disability or global developmental delay alone.
“Spectrum” reflects the wide variation in presentation, language ability, cognitive level, and support needs. The DSM-5-TR uses three severity levels (Level 1 “requiring support” through Level 3 “requiring very substantial support”), separately rated for social communication and restricted/repetitive behaviors.
Early Signs by Age
The CDC’s Learn the Signs. Act Early. resources list red flags that warrant evaluation. By 9 months: little or no eye contact, no shared expressions, no back-and-forth sounds. By 12 months: no babbling, no gestures (waving, pointing, reaching), no response to name. By 16 months: no spoken words. By 24 months: no two-word meaningful phrases (not just imitating). At any age: loss of speech, babbling, or social skills.
Other features that often appear early but are not in themselves diagnostic include: hand flapping, toe walking, lining up toys repetitively, intense focus on parts of objects (wheels of toy cars), strong reactions to sensory inputs (sounds, textures), strong preferences for routine, and unusual eating patterns.
Screening and Diagnosis
The AAP recommends autism-specific screening at the 18- and 24-month well-child visits using a validated tool — most commonly the M-CHAT-R/F (Modified Checklist for Autism in Toddlers, Revised with Follow-Up). General developmental surveillance happens at every visit. Positive screens lead to a follow-up interview and, if still positive, referral for comprehensive developmental evaluation.
Diagnosis is made by a developmental pediatrician, child psychiatrist, child psychologist, or pediatric neurologist using DSM-5-TR criteria, often supported by structured tools like the ADOS-2 (Autism Diagnostic Observation Schedule) and ADI-R (Autism Diagnostic Interview-Revised). Comprehensive evaluation also assesses cognitive functioning, language, adaptive behavior, and any co-occurring conditions like ADHD, anxiety, or intellectual disability. Genetic testing (chromosomal microarray and fragile X) is recommended at the time of diagnosis per AAP genetics guidelines.
Diagnostic wait times in the U.S. average several months to over a year in many areas. Early Intervention referral does not require a diagnosis and should not wait for one — see the section below.
Causes and Risk Factors
Autism has a strong genetic component, with heritability estimates of 60-90% in twin studies. Hundreds of genes have been associated with ASD; many cases are polygenic, while others involve specific syndromic conditions (fragile X syndrome, tuberous sclerosis, Rett syndrome). Environmental contributors with reasonable evidence include advanced parental age, prematurity, valproate exposure in pregnancy, and certain perinatal complications. Vaccines do not cause autism — this has been thoroughly disproven across more than two dozen large studies, including a 657,000-child Danish cohort.
Early Intervention and Evidence-Based Therapies
Every U.S. state operates a federally funded Early Intervention program (Part C of IDEA) for children under 3 with developmental concerns. Referral does not require diagnosis. Evaluation is free regardless of insurance, and qualifying children receive services at low or no cost. From age 3 onward, services transition to school-based special education (Part B of IDEA), also free.
Evidence-based interventions for autism include: applied behavior analysis (ABA) — the most studied behavioral intervention, with strong evidence for early intensive ABA (often the Early Start Denver Model in toddlers); speech-language therapy targeting social communication; occupational therapy for sensory processing, motor skills, and daily living; structured teaching approaches (TEACCH); and parent-mediated interventions. Approaches differ in intensity, methodology, and goals — there is no single “best” therapy across all children.
Medications do not treat core autism symptoms but address co-occurring conditions: aripiprazole and risperidone are FDA-approved for irritability and aggression in autism; SSRIs may help anxiety; ADHD medications help attention; melatonin is widely used for sleep disturbance.
Common Co-Occurring Conditions
Children with autism have higher rates of ADHD (about 30-50%), anxiety disorders (up to 40%), depression (especially in adolescence), seizure disorders (about 25% have an epileptic syndrome by adulthood), gastrointestinal issues, sleep disturbance, intellectual disability (about one-third of children with ASD), and feeding selectivity. Comprehensive care addresses these alongside core ASD support. Routine well-child visits remain important and may need adjustments — sensory accommodations, visual schedules, and longer appointment times.
Family Support and Insurance
Most U.S. states require ACA-compliant insurance plans to cover autism-related therapies including ABA, though specifics vary. Medicaid covers ABA in nearly all states. Federal disability benefits (SSI), state Medicaid waiver programs, and respite care may be available depending on income, severity, and state. Schools provide free educational services through IEPs (Individualized Education Programs) starting at age 3 in most states.
Parent-led organizations, advocacy groups, and autism-specific support networks provide community, training, and peer connection. CDC autism resources and NICHD autism information are reliable starting points for family education.
When to Talk to Your Pediatrician
Bring up specific concerns at the next well-child visit, or sooner. Concrete examples are more useful than general worries: “By 18 months, my child has fewer than 3 words and does not respond to name even at home in a quiet room.” Ask for screening with a validated tool, and request referral to Early Intervention regardless of whether your pediatrician thinks ASD is likely — the threshold for EI referral is concern, not diagnosis.
When to seek emergency care: Call 911 or go to the emergency room for any child with seizure activity (especially first seizure), self-injurious behavior causing significant harm, severe dehydration from food refusal, suicidal statements or behaviors in older children, or any acute medical emergency. Autism itself is not a medical emergency, but co-occurring conditions sometimes are.
Frequently Asked Questions
How young can autism be reliably diagnosed?
Reliable diagnosis is possible at 18-24 months with experienced clinicians and validated tools. Some signs are detectable earlier. Diagnostic stability (whether a diagnosis at age 2 holds at age 5+) is high in most studies, particularly for children with clearer presentations.
Should I wait to refer if I’m not sure?
No. Refer to Early Intervention based on concern, not diagnosis. EI evaluation is free, qualifies children for services without an ASD diagnosis, and earlier intervention is associated with better outcomes. The “wait and see” approach is no longer recommended for any concerning developmental pattern.
Is ABA the only treatment?
No. ABA has the most evidence for early intensive intervention, but speech, OT, parent-mediated programs, naturalistic developmental behavioral interventions, and structured teaching are all evidence-based. Treatment plans should match each child’s goals and family preferences. Intensity and methodology vary by child.
Will my child with autism live independently?
Outcomes vary widely. Children with average or above-average cognitive ability and supportive education often achieve substantial independence in adulthood. Children with co-occurring intellectual disability typically require ongoing support. Adolescent and adult outcomes have improved over the past decades with earlier intervention and better educational supports.
The Bottom Line on Autism Spectrum Disorder
Autism spectrum disorder is a developmental difference, not a tragedy or a disease, and many people on the spectrum lead full lives. Early identification — through routine screening at well-child visits at 18 and 24 months — combined with timely Early Intervention services produces the best functional outcomes. Pursue evaluation when concerns arise, refer regardless of diagnosis status, and use the federally funded EI/IDEA system that every American family is entitled to. Autism fits within the larger landscape of developmental milestones and pediatric neurodevelopmental conditions that benefit from coordinated, family-centered care.